Anastrozole Tablets

BRITISH DRAGON ANASTROZOLE

Anastrozole Tablets by British Dragon is an oral medication containing Anastrozole as the active substance. Each tablet typically provides 1 mg of Anastrozole. Anastrozole belongs to the class of aromatase inhibitors, designed to manage estrogen levels.

DRUG COMPOSITION

Each tablet of Anastrozole contains 1 mg of Anastrozole.

PHARMACEUTICAL FORM

Anastrozole is formulated in tablet form, facilitating easy oral administration.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antineoplastic and immunomodulating agents; ATC code: L02BG03.

PHARMACOLOGICAL PROPERTIES

Anastrozole is an aromatase inhibitor that effectively suppresses the conversion of androgens to estrogens, reducing estrogen levels in the body. This property is particularly useful in hormone-sensitive conditions.

PROFILE

• Chemical name: 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
• Chemical formula: C17H19N5
• Percentage of anabolic activity: Not a steroid
• Percentage of androgenic activity: Not a steroid
• Active half life: 2 days
• Recommended dosage: 1 mg each other day
• Acne: no
• Bloating (water retention): no
• HBR: no
• Hepatic toxicity: no
• Aromatization: no

THERAPEUTICAL INDICATIONS

Anastrozole is primarily prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women.

DOSES AND METHOD OF ADMINISTRATION

Dosage and administration are typically determined by a healthcare professional based on the specific condition being treated. Anastrozole is taken orally, usually once a day.

CYCLE/STACKING

Solo cycle:

• Anastrozole is commonly used on its own to manage estrogen levels in breast cancer treatment. The dosage is adjusted according to the individual's response.

Cutting cycle:

• Anastrozole may be incorporated into cutting cycles in combination with other compounds to mitigate estrogen-related side effects.

Bulking cycle:

• Anastrozole is not typically a component of bulking cycles, as it does not contribute to muscle growth. However, it may be used to control estrogen levels if necessary.

POST CYCLE THERAPY

Anastrozole is not a standard component of post-cycle therapy for anabolic steroid use. However, it may be used in specific cases to manage estrogen rebound.

SIDE EFFECTS

Potential side effects include hot flashes, joint pain, and nausea. More severe side effects are rare.

CONTRAINDICATIONS

Anastrozole is contraindicated in individuals with hypersensitivity to the drug and in premenopausal women. Caution is advised in patients with liver disorders.

OVERDOSE

There is limited information on the effects of overdose. In case of overdose, seek medical attention.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Caution is advised in individuals with a history of liver disorders. Regular monitoring of liver function may be recommended during treatment.

INTERACTIONS WITH OTHER DRUGS

Anastrozole may interact with certain medications, including estrogen-containing therapies. Inform healthcare providers of all medications being taken.

PRESENTATION, PACKAGING

1 mg per tablet, 50 tablets in sachet.

STORAGE

Store Anastrozole in a cool, dry place, protected from light.

LEGAL STATUS

Anastrozole is a prescription medication and is subject to legal regulations.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

British Dragon
Europe

EXTERNAL LINKS

• Anastrozole Wiki, wikipedia.org
• Anastrozole Uses, Side Effects & Warnings, drugs.com
• Anastrozole Oral: Uses, Side Effects, Interactions, Pictures, webmd.com.